Dr Jean-Hugues SalmonRhumatologue à Reims

2026Joint bone spinePubMed

Cardiovascular risk assessment using the DAS28-GGT score in rheumatoid arthritis patients initiating JAK inhibitors: Results from the MAJIK-SFR registry

2026Joint bone spinePubMed

Impact of regulatory events on JAK inhibitor prescribing in rheumatoid arthritis: Insights from the French MAJIK Registry

2026Rheumatology and therapyPubMed

Correction to: Comparative Effectiveness, Time to Discontinuation, and Patient-Reported Outcomes with Baricitinib in Rheumatoid Arthritis: 2-Year Data from the Multinational, Prospective Observational RA-BE-REAL Study in European Patients

2025RMD openPubMed

Evaluation of rheumatoid arthritis-associated interstitial lung disease in patients treated with JAK inhibitors: a MAJIK-SFR cohort study

2024Joint bone spinePubMed

2024 update of the recommendations of the French Society of Rheumatology for the diagnosis and management of patients with rheumatoid arthritis

2024RMD openPubMed

Urinary methotrexate dosage in rheumatoid arthritis, in patients treated for at least 6 months: a potential marker of adherence

2024Arthritis & rheumatology (Hoboken, N.J.)PubMed

Towards the Lowest Efficacious Dose: Results From a Multicenter Noninferiority Randomized Open-Label Controlled Trial Assessing Tocilizumab or Abatacept Injection Spacing in Rheumatoid Arthritis in Remission

2023Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapiePubMed

A new pharmacokinetic model of urinary methotrexate to assess adherence in rheumatoid arthritis

2023Rheumatology and therapyPubMed

Comparative Effectiveness, Time to Discontinuation, and Patient-Reported Outcomes with Baricitinib in Rheumatoid Arthritis: 2-Year Data from the Multinational, Prospective Observational RA-BE-REAL Study in European Patients

2023Rheumatology and therapyPubMed

The RA-BE-REAL Multinational, Prospective, Observational Study in Patients with Rheumatoid Arthritis Receiving Baricitinib, Targeted Synthetic, or Biologic Disease-Modifying Therapies: a 6-Month Interim Analysis

2021Expert opinion on drug safetyPubMed

Factors affecting persistence with biologic treatments in patients with rheumatoid arthritis: a systematic literature review

2020Journal of clinical medicinePubMed

Actual Persistence of Abatacept in Rheumatoid Arthritis: Results of the French-Ric Network

2019Seminars in arthritis and rheumatismPubMed

Safety of combination therapy with two bDMARDs in patients with rheumatoid arthritis: A systematic review and meta-analysis

2019Rheumatology and therapyPubMed

Tocilizumab Effectiveness After Switching from Intravenous to Subcutaneous Route in Patients with Rheumatoid Arthritis: The RoSwitch Study

2018TherapiePubMed

[Effectiveness, therapeutic maintenance and reasons for stopping tocilizumab (TCZ): A retrospective and monocentric study in 88 patients followed for rheumatoid arthritis (RA) at the Reims university hospital]

2018Rheumatology (Oxford, England)PubMed

Serious infusion-related reaction after rituximab, abatacept and tocilizumab in rheumatoid arthritis: prospective registry data

2018Joint bone spinePubMed

Incidence of paradoxical reactions in patients treated with tocilizumab for rheumatoid arthritis: Data from the French registry REGATE

2017Clinical rheumatologyPubMed

Disease-modifying anti-rheumatic drug effect of denosumab on radiographic progression in rheumatoid arthritis: a systematic review of the literature

2026International journal of chronic obstructive pulmonary diseasePubMed

Questionnaire-Based Assessment of Physical Disability in COPD

2025Journal of clinical medicinePubMed

Evaluation of the BIOSECURE Questionnaire in Patients Followed for Inflammatory Rheumatological and Gastrointestinal Diseases Through the Analysis of This Questionnaire

2024Aging clinical and experimental researchPubMed

"The least significant change on bone mineral density scan increased in patients with higher degrees of obesity"

2022Joint bone spinePubMed

Treatment of Trigger finger by ultrasound-guided needle release of a1 pulley: A series of 105 cases

2026Joint bone spinePubMed

Cardiovascular risk assessment using the DAS28-GGT score in rheumatoid arthritis patients initiating JAK inhibitors: Results from the MAJIK-SFR registry

2026Joint bone spinePubMed

Impact of regulatory events on JAK inhibitor prescribing in rheumatoid arthritis: Insights from the French MAJIK Registry

2026Rheumatology and therapyPubMed

Correction to: Comparative Effectiveness, Time to Discontinuation, and Patient-Reported Outcomes with Baricitinib in Rheumatoid Arthritis: 2-Year Data from the Multinational, Prospective Observational RA-BE-REAL Study in European Patients

2025RMD openPubMed

Evaluation of rheumatoid arthritis-associated interstitial lung disease in patients treated with JAK inhibitors: a MAJIK-SFR cohort study

2024Arthritis & rheumatology (Hoboken, N.J.)PubMed

Towards the Lowest Efficacious Dose: Results From a Multicenter Noninferiority Randomized Open-Label Controlled Trial Assessing Tocilizumab or Abatacept Injection Spacing in Rheumatoid Arthritis in Remission

2020Journal of clinical medicinePubMed

Actual Persistence of Abatacept in Rheumatoid Arthritis: Results of the French-Ric Network

2019Rheumatology and therapyPubMed

Tocilizumab Effectiveness After Switching from Intravenous to Subcutaneous Route in Patients with Rheumatoid Arthritis: The RoSwitch Study

2018TherapiePubMed

[Effectiveness, therapeutic maintenance and reasons for stopping tocilizumab (TCZ): A retrospective and monocentric study in 88 patients followed for rheumatoid arthritis (RA) at the Reims university hospital]

2026Joint bone spinePubMed

Health care practices in symptomatic knee and hip osteoarthritis patients: The KHOALA cohort

2023Diagnostics (Basel, Switzerland)PubMed

Prognostic Factors Related to Clinical Response in 210 Knees Treated by Platelet-Rich Plasma for Osteoarthritis

2019Osteoarthritis and cartilagePubMed

Health resource use and costs of symptomatic knee and/or hip osteoarthritis

2018PharmacoEconomicsPubMed

Cost Effectiveness of Intra-Articular Hyaluronic Acid and Disease-Modifying Drugs in Knee Osteoarthritis

2026Joint bone spinePubMed

Platelet-rich plasma versus corticosteroids in facet joint syndrome: A controlled, randomized, double-blind study

2025Healthcare (Basel, Switzerland)PubMed

Effect of Virtual Reality on Pain and Anxiety During Epidural Steroid Injection in Patients with Lumbar Radicular Pain: An Open-Label Randomized Trial

2025Journal of clinical medicinePubMed

Lumbar Tractions in Radicular Pain Caused by Herniated Disc: Randomised, Open-Label, Superiority, and Controlled Trial on 424 Participants

2022Frontiers in medicinePubMed

Differential retention of adalimumab and etanercept biosimilars compared to originator treatments: Results of a retrospective French multicenter study

2020Journal of Crohn's & colitisPubMed

Severe Attack of Henoch-Schönlein Purpura With Neurological Involvement During Adalimumab Treatment for Crohn's Disease

2026Joint bone spinePubMed

Platelet-rich plasma versus corticosteroids in facet joint syndrome: A controlled, randomized, double-blind study

2018Joint bone spinePubMed

Adverse effect of corticosteroid therapy: Central serous chorioretinopathy

2024RMD openPubMed

Urinary methotrexate dosage in rheumatoid arthritis, in patients treated for at least 6 months: a potential marker of adherence

2023Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapiePubMed

A new pharmacokinetic model of urinary methotrexate to assess adherence in rheumatoid arthritis

2026Joint bone spinePubMed

Cardiovascular risk assessment using the DAS28-GGT score in rheumatoid arthritis patients initiating JAK inhibitors: Results from the MAJIK-SFR registry

2023Joint bone spinePubMed

Recommendations for assessing the risk of cardiovascular disease and venous thromboembolism before the initiation of targeted therapies for chronic inflammatory rheumatic diseases

2024Scientific reportsPubMed

Retention rate of subcutaneous TNF inhibitors in axial spondyloarthritis in a multicentre study from the RIC-FRANCE network

2018Joint bone spinePubMed

Association between hidradenitis suppurativa and spondyloarthritis

2021Rheumatology (Oxford, England)PubMed

Secukinumab and ustekinumab treatment in psoriatic arthritis: results of a direct comparison

2021Rheumatology (Oxford, England)PubMed

Secukinumab and ustekinumab treatment in psoriatic arthritis: results of a direct comparison

2024RMD openPubMed

Eosinopenia and routine inflammatory biomarkers are helpful for the diagnosis of infection in patients treated with IL-6 pathway antagonists

2021Frontiers in medicinePubMed

Prevalence and Impact of Rheumatologic Pain in Cystic Fibrosis Adult Patients

2024BMC nephrologyPubMed

Urate lowering therapy in patients starting hemodialysis limit gout flares occurrence: ten years retrospective study

2024Human vaccines & immunotherapeuticsPubMed

Polymyalgia rheumatica and giant cell arteritis following COVID-19 vaccination: Results from a nationwide survey

2017Clinical rheumatologyPubMed

Disease-modifying anti-rheumatic drug effect of denosumab on radiographic progression in rheumatoid arthritis: a systematic review of the literature

2023Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the LiverPubMed

Efficacy and safety of combination targeted therapies in immune-mediated inflammatory disease: the COMBIO study

2024Human vaccines & immunotherapeuticsPubMed

Polymyalgia rheumatica and giant cell arteritis following COVID-19 vaccination: Results from a nationwide survey

2025Joint bone spinePubMed

French recommendations for assessing and managing the risk of cancer before the initiation of targeted therapies for chronic rheumatic inflammatory diseases

2021Rheumatology (Oxford, England)PubMed

Secukinumab and ustekinumab treatment in psoriatic arthritis: results of a direct comparison

2025Healthcare (Basel, Switzerland)PubMed

Effect of Virtual Reality on Pain and Anxiety During Epidural Steroid Injection in Patients with Lumbar Radicular Pain: An Open-Label Randomized Trial

2019 · Reims

La prise en charge de l'arthrose des membres inférieurs ; aspect de santé publique